Slow Walking Speed May Signal Onset of Alzheimer's
the Psychiatry Advisor take:
The gait of an older adult may be an indicator of whether or not they develop Alzheimer’s disease later on.
Natalia del Campo, PhD, of Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, France, and colleagues examined 128 people, average age of 76 years old, without dementia but considered at high risk for it due to memory problems. Positron emission tomography scans were conducted on their brains, and 48% of participants had level of beta-amyloid at levels high enough to be associated with dementia.
Researchers also tested the subjects’ thinking and memory skills, as well as their ability to complete everyday tasks. Mild cognitive impairment was found in 46% of them.
The participants’ walking speed was also measured. There was a link between slow walking and speed and amyloid levels in certain areas of the brain, including one responsible for motor functions, the researchers reported in the journal Neurology.
After comparing the speed people walked with and without accounting for amyloid amounts, the researchers found up to 9% of the difference were the result of amyloid levels. However, the connection between amyloid and walking speed was not altered when accounting for age, education, or extent of memory problems.
“It’s possible that having subtle walking disturbances in addition to memory concerns may signal Alzheimer's disease, even before people show any clinical symptoms,” del Campo said in a statement.
Researchers found a link between slow walking and speed and amyloid levels in certain areas of the brain.
The speed at which elderly people walk may indicate their likelihood of developing Alzheimer's disease, according to research published in Neurology.
Researchers led by Natalia del Campo, PhD, of the Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, in France, hypothesized that a slower speed of walking may be related to the amount of amyloid plaque people with Alzheimer's have built up in their brains, even if they do not yet have external symptoms of Alzheimer's disease.
Amyloid precursor protein (APP) occurs throughout the body. The amyloid hypothesis proposes that there is a fault with the processing of APP in the brain, leading to the production of a short fragment of APP, a sticky protein known as beta-amyloid.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk
- FDA to Review Lumateperone for Treatment of Schizophrenia
- Evzio Authorized Generic Soon to Be Available
- AMA Survey Collects Advice for Physicians Approaching Retirement
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Cognition, Depression, and Limited Functioning Linked in Middle Age
- Coping With Challenges When Working the Holidays
- Lithium Preferred Method of Maintenance Monotherapy in Older Adults With Bipolar Disorder
- Hypobetalipoproteinemia Associated With Aggression and Schizophrenia
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information